Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Session in collaboration with AACR - The expanding portfolio of targeted and cellular therapies in oncology-mechanisms of action and proofs of principle

Biparatopic antibodies targeting FGFR2 for the treatment of cholangiocarcinoma and gastric cancer

Date

08 Dec 2024

Session

Session in collaboration with AACR - The expanding portfolio of targeted and cellular therapies in oncology-mechanisms of action and proofs of principle

Topics

Targeted Therapy

Tumour Site

Gastric Cancer; Hepatobiliary Cancers

Presenters

William Sellers

Authors

W. Sellers

Author affiliations

Broad Institute, 02142 - Cambridge/US

Resources

This content is available to ESMO members and event participants.

Resources from the same session

08 Dec 2024

Multi specific immunotherapeutic engagers

Presenter: Camille Rolin

Session: Session in collaboration with AACR - The expanding portfolio of targeted and cellular therapies in oncology-mechanisms of action and proofs of principle

Resources:

Slides

Webcast

08 Dec 2024

CLAUDIN-6 CAR-T + mRNA vaccine

Presenter: John Haanen

Session: Session in collaboration with AACR - The expanding portfolio of targeted and cellular therapies in oncology-mechanisms of action and proofs of principle

Resources:

Slides

Webcast

08 Dec 2024

Q&A and discussion

Session: Session in collaboration with AACR - The expanding portfolio of targeted and cellular therapies in oncology-mechanisms of action and proofs of principle

Resources:

Webcast